We are live on ! Find out more
PMAM

Picton Mahoney Asset Management Portfolio holdings

AUM $13.5B
1-Year Est. Return 51.47%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+51.47%
3 Year Est. Return
+209.24%
5 Year Est. Return
+374.21%
10 Year Est. Return
+1,935.98%
AUM
$4.9B
AUM Growth
+$1.84B
Cap. Flow
+$478M
Cap. Flow %
9.75%
Top 10 Hldgs %
40.93%
Holding
988
New
150
Increased
237
Reduced
164
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 12.99%
2 Financials 12.69%
3 Consumer Discretionary 5.48%
4 Industrials 4.08%
5 Communication Services 4.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBIN icon
551
Merchants Bancorp
MBIN
$2.54B
$9K ﹤0.01%
258
+92
+55% +$3.72K
ZOOZW
552
ZOOZ Strategy Ltd Warrant
ZOOZW
$189K
$9K ﹤0.01%
162,500
AGEN
553
Agenus
AGEN
$311M
$8K ﹤0.01%
+2,936
New +$10.9K
BMEA icon
554
Biomea Fusion
BMEA
$94.2M
$8K ﹤0.01%
2,108
+1,711
+431% +$13.6K
HYLN icon
555
Hyliion Holdings
HYLN
$757M
$8K ﹤0.01%
3,183
+449
+16% +$1.25K
OPTXW icon
556
Syntec Optics Holdings Warrant
OPTXW
$22.6M
$8K ﹤0.01%
75,000
ABPWW
557
DELISTED
Abpro Holdings Warrant
ABPWW
$8K ﹤0.01%
125,000
VMCAW
558
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$8K ﹤0.01%
225,000
ATNM icon
559
Actinium Pharmaceuticals
ATNM
$29.5M
$7K ﹤0.01%
+5,968
New +$9.26K
UIS icon
560
Unisys
UIS
$205M
$7K ﹤0.01%
1,217
+445
+58% +$3.1K
CVGI icon
561
Commercial Vehicle Group
CVGI
$130M
$6K ﹤0.01%
+2,423
New +$6.47K
FATE icon
562
Fate Therapeutics
FATE
$310M
$6K ﹤0.01%
3,585
+1,824
+104% +$4.6K
ORN icon
563
Orion Group Holdings
ORN
$395M
$6K ﹤0.01%
800
+88
+12% +$636
BRLSW icon
564
Borealis Foods Inc Warrant
BRLSW
$6K ﹤0.01%
75,000
ITCI
565
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6K ﹤0.01%
72
+26
+57% +$2.14K
RFAIR
566
RF Acquisition Corp II Right
RFAIR
$5K ﹤0.01%
100,000
CHEB.WS
567
DELISTED
Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHEB.WS
$5K ﹤0.01%
100,000
BPMC
568
DELISTED
Blueprint Medicines
BPMC
$4K ﹤0.01%
40
+15
+60% +$1.37K
CEVA icon
569
CEVA Inc
CEVA
$883M
$4K ﹤0.01%
+108
New +$3K
CYRX icon
570
CryoPort
CYRX
$766M
$4K ﹤0.01%
572
+105
+22% +$783
INO icon
571
Inovio Pharmaceuticals
INO
$93.9M
$4K ﹤0.01%
+1,923
New +$8.51K
MRSN
572
DELISTED
Mersana Therapeutics
MRSN
$4K ﹤0.01%
115
+15
+15% +$776
TVGNW icon
573
Tevogen Inc. Warrant
TVGNW
$911K
$4K ﹤0.01%
75,000
CSLMW
574
DELISTED
CSLM Acquisition Corp. Warrant
CSLMW
$4K ﹤0.01%
50,000
GB.WS
575
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
$3K ﹤0.01%
123,907

Similar funds

Picton Mahoney Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Picton Mahoney Asset Management held 988 positions worth $4.9B, up 60% from $3.06B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Picton Mahoney Asset Management deployed $478M of net new capital in Q4 2024, opening 150 new positions and adding to 237 existing holdings. Its largest new stake was Summit Materials, Inc. Class A Common Stock: 590,000 shares worth $29.9M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Applovin, an estimated $19.9M trimmed.

  • Picton Mahoney Asset Management's largest Q4 2024 buy was Summit Materials, Inc. Class A Common Stock: 590,000 shares worth $29.9M.
  • Picton Mahoney Asset Management added most to LPL Financial in Q4 2024, an estimated $16.8M increase.
  • Picton Mahoney Asset Management's biggest Q4 2024 reduction was Applovin, cutting an estimated $19.9M.
  • Picton Mahoney Asset Management fully exited Stericycle Inc in Q4 2024, selling an estimated $36.6M.
  • Picton Mahoney Asset Management's ten largest holdings make up 41% of its $4.9B portfolio in Q4 2024.
  • Picton Mahoney Asset Management opened 150 new positions and closed 137 in Q4 2024.
  • Picton Mahoney Asset Management's portfolio value rose 60% quarter-over-quarter to $4.9B.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.